Testing must be going well if they are looking for partners to ramp up production.
I don't see us dropping below $30 again because the anticipation of news in December will have the trading range rising. Low 31's yes, but trade on the assumption that the range will be rising.
I am assuming the 2:20 pm time for the London presentation tomorrow is local, which means early morning U.S. All the more reason to buy before the close for a morning pop.
Starting another round trip trade for me down here. As long as it trades in a range, trade a portion of your shares. With the conference tomorrow, I would be all in here, since we have a good shot at a pop tomorrow during the conference.
Someone already infected won't be treated with the vaccine. There should be news before year end on the initial results of human trials and potentially hundreds of thousands of doses available by then also, according to the CEO. That should make for a huge rally in NLNK.
Hundreds of thousands of doses a new Ebola vaccine could be ready to send to West Africa within the next three months, NewLink Genetics CEO Charles Link said Tuesday.
"We think by the end of the year we could have hundreds of thousands of doses, if the dose that's chosen is a moderate-size dose," he said. "It could be hundreds of thousands of doses, maybe more."
Looking for a nice bump again.
My suggestion is to trade a portion of your shares until about Dec 10th, then buy and hold tight for vaccine news that should be coming based on the CEO comments on CNBC a few weeks back.
You need to learn to trade the fluctuations. While it stays within a range, make some money by trading it, but keep a core amount of shares for when it breaks out to the upside.
How can you go wrong here? Wonder why they or someone else doesn't buy them out.
Unbelievable! Expect more people to have it because he rode the subway, taxi, and went bowling yesterday. Wonder what he did with his girlfriend. How stupid can you be?